These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 27536427)

  • 1. The assessment of the optimal duration of early intervention with montelukast in the treatment of Japanese cedar pollinosis symptoms induced in an artificial exposure chamber.
    Hashiguchi K; Okubo K; Wakabayashi K; Tanaka N; Watada Y; Suematsu K; Gotoh M
    J Drug Assess; 2012; 1(1):40-7. PubMed ID: 27536427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Montelukast for the Treatment of Children With Japanese Cedar Pollinosis Using an Artificial Exposure Chamber (OHIO Chamber).
    Hashiguchi K; Okubo K; Inoue Y; Numaguchi H; Tanaka K; Oshima N; Mehta A; Nishida C; Saito I; Philip G
    Allergy Rhinol (Providence); 2018; 9():2152656718783599. PubMed ID: 30027002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pranlukast dry syrup inhibits symptoms of Japanese cedar pollinosis in children using OHIO Chamber.
    Wakabayashi K; Hashiguchi K; Kanzaki S; Fujioka M; Tanaka N; Kawashima K; Suematsu K; Yamamotoya H; Iwasaki M; Gotoh M; Horibe S; Naito K; Okubo K
    Allergy Asthma Proc; 2012; 33(1):102-9. PubMed ID: 22370535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-controlled study with OHIO chamber of prophylactic pranlukast for children with Japanese cedar pollinosis: TOPIC-J III study.
    Hosoya K; Masuno S; Hashiguchi K; Okubo K
    J Drug Assess; 2014; 3(1):51-9. PubMed ID: 27536454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine antagonist Bepotastine suppresses nasal symptoms caused by Japanese cedar and cypress pollen exposure.
    Kanzaki S; Hashiguchi K; Wakabayashi KI; Suematsu K; Okubo K
    J Drug Assess; 2016; 5(1):15-23. PubMed ID: 27785375
    [No Abstract]   [Full Text] [Related]  

  • 6. Bepotastine besilate OD tablets suppress nasal symptoms caused by Japanese cedar pollen exposure in an artificial exposure chamber (OHIO Chamber).
    Hashiguchi K; Tang H; Fujita T; Suematsu K; Gotoh M; Okubo K
    Expert Opin Pharmacother; 2009 Mar; 10(4):523-9. PubMed ID: 19216705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of bilastine in Japanese cedar pollinosis using an artificial exposure chamber (OHIO Chamber).
    Hashiguchi K; Wakabayashi KI; Togawa M; Saito A; Okubo K
    Allergol Int; 2017 Jan; 66(1):123-131. PubMed ID: 27475625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial of pranlukast inhibitory effect for cedar exposure using an OHIO chamber.
    Endo S; Gotoh M; Okubo K; Hashiguchi K; Suzuki H; Masuyama K
    J Drug Assess; 2012; 1(1):48-54. PubMed ID: 27536428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary study on Japanese cedar pollinosis in an artificial exposure chamber (OHIO Chamber).
    Hashiguchi K; Tang H; Fujita T; Tsubaki S; Fujita M; Suematsu K; Gotoh M; Okubo K
    Allergol Int; 2007 Jun; 56(2):125-30. PubMed ID: 17384532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of fluticasone furoate nasal spray and levocetirizine in patients with Japanese cedar pollinosis subjected to an artificial exposure chamber.
    Hashiguchi K; Kanzaki S; Wakabayashi K; Tanaka N; Kawashima K; Suematsu K; Tokunaga S; Ogawa K; Okubo K
    J Drug Assess; 2013; 2(1):94-105. PubMed ID: 27536443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation study of the OHIO Chamber in patients with Japanese cedar pollinosis.
    Hashiguchi K; Tang H; Fujita T; Suematsu K; Tsubaki S; Nagakura H; Kitajima S; Gotoh M; Okubo K
    Int Arch Allergy Immunol; 2009; 149(2):141-9. PubMed ID: 19127071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit.
    Enomoto T; Lu HQ; Yin M; Sakoda T; Dake Y; Enomoto K; Ide T; Cheng L
    J Investig Allergol Clin Immunol; 2009; 19(4):299-305. PubMed ID: 19639726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive biological evaluation of response to pranlukast treatment in pediatric patients with Japanese cedar pollinosis.
    Gotoh M; Okubo K; Hashiguchi K; Wakabayashi K; Kanzaki S; Tanaka N; Fujioka M; Kawashima K; Suematsu K; Sasaki K; Iwasaki M; Yamamotoya H
    Allergy Asthma Proc; 2012; 33(6):459-66. PubMed ID: 23394502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
    Jacobs R; Martin B; Hampel F; Toler W; Ellsworth A; Philpot E
    Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
    Okamoto Y; Okubo K; Yonekura S; Hashiguchi K; Goto M; Otsuka T; Murata T; Nakao Y; Kanazawa C; Nagakura H; Okawa T; Nakano K; Hisamitsu M; Kaneko S; Konno A
    Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis.
    Yamamoto H; Yamada T; Sakashita M; Kubo S; Susuki D; Tokunaga T; Ogi K; Terasawa Y; Yamashita S; Kayano Y; Masada M; Kimura Y; Fujieda S
    Allergy Asthma Proc; 2012; 33(2):e17-22. PubMed ID: 22525385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.
    Di Lorenzo G; Pacor ML; Pellitteri ME; Morici G; Di Gregoli A; Lo Bianco C; Ditta V; Martinelli N; Candore G; Mansueto P; Rini GB; Corrocher R; Caruso C
    Clin Exp Allergy; 2004 Feb; 34(2):259-67. PubMed ID: 14987306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of nasal steroid with antihistamine in prophylactic treatment against pollinosis using an environmental challenge chamber.
    Yamamoto H; Yonekura S; Sakurai D; Katada K; Inamine A; Hanazawa T; Horiguchi S; Okamoto Y
    Allergy Asthma Proc; 2012; 33(5):397-403. PubMed ID: 23026181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Desloratadine and Levocetirizine in Patients with Cedar Pollen-Induced Allergic Rhinitis: A Randomized, Double-Blind Study.
    Yonekura S; Okamoto Y; Sakurai D; Iinuma T; Sakurai T; Yoneda R; Kurita J; Hanazawa T; Kawasaki Y
    Int Arch Allergy Immunol; 2019; 180(4):274-283. PubMed ID: 31618733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet.
    Gotoh M; Yonekura S; Imai T; Kaneko S; Horikawa E; Konno A; Okamoto Y; Okubo K
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1287-1297.e8. PubMed ID: 30537561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.